| Gene symbol | S | Synonyms | None | Type of gene | protein-coding |
| Chromosome | None | Map location | NC_003977.2 (2850..3182) NC_003977.2 (1..837) | dbXrefs | |
| Description | large envelope protein;middle envelope protein;small envelope protein | ||||
| GTO ID | GTC3071 |
| Trial ID | NCT05417932 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | S |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | SCG101 |
| HLA | HLA-A*02 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase 1/ 2, Multicenter Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma |
| Year | 2022 |
| Country | China|Singapore|United States |
| Company sponsor | SCG Cell Therapy Pte. Ltd. |
| Other ID(s) | SCG101-UR-103 |
| Cohort 1 | |||||||||
|
|||||||||